The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
Open Access
- 29 April 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (35)
- https://doi.org/10.3410/m1-35
Abstract
The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?This publication has 14 references indexed in Scilit:
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- Premature atherosclerotic cardiovascular disease in systemic lupus erythematosusArthritis & Rheumatism, 2007
- Risk of Myocardial Infarction in Patients With PsoriasisJAMA, 2006
- Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.2006
- Patterns of cardiovascular risk in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2006
- Cardiovascular death in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenThe New England Journal of Medicine, 2004
- Making an impact on mortality in rheumatoid arthritis: Targeting cardiovascular comorbidityArthritis & Rheumatism, 2004
- CRP as a Mediator of DiseaseCirculation, 2004
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenThe New England Journal of Medicine, 1997